Biology of the TAM Receptors
Open accessThe DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
The TAM receptors--Tyro3, Axl, and Mer--comprise a unique family of receptor tyrosine kinases, in that as a group they play no essential role in embryonic development. Instead, they function as homeostatic regulators in adult tissues and organ systems that are subject to continuous challenge and renewal throughout life. Their regulatory roles are prominent in the mature immune, reproductive, hematopoietic, vascular, and nervous systems. The TAMs and their ligands--Gas6 and Protein S--are essential for the efficient phagocytosis of apoptotic cells and membranes in these tissues; and in the immune system, they act as pleiotropic inhibitors of the innate inflammatory response to pathogens. Deficiencies in TAM signaling are thought to contribute to chronic inflammatory and autoimmune disease in humans, and aberrantly elevated TAM signaling is strongly associated with cancer progression, metastasis, and resistance to targeted therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myelin debris clearance during cuprizone consumption is regulated by receptor tyrosine kinases, such as MER proto-oncogene, tyrosine kinase (MERTK) that recognize phosphatidylserine on apoptotic cells [198, 199].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [199]
In the citing paper
“Activation of the tyrosine kinase of TAM receptors upon ligand binding recruits the p85 subunit of PI3K and activates PI3K/Akt signaling [147–150].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [148]
In the citing paper
“Microglia also express several families of receptors that enable phagocytosis or endocytosis of apoptotic cells, protein aggregates, and lipoprotein particles. These receptors include scavenger receptors, such as CD36, SR1, and MARCO (20); LDL receptor family members, such as LDLR, ApoER2, and VLDL (21); and three receptor tyrosine kinases, Tyro3, Axl, and Mertk (TAM) (22).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [22]
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145 · cited 1×
“1994) confirmed their segregation into a structurally distinctive family of orphan RTKs (Manning et al. 2002b).”
BackgroundMembrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193 · cited 1×
“3) (Iwasaki and Medzhitov 2004).”
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697 · cited 1×
“Here, a large genome-wide association study identified polymorphisms in the Mertk gene as risk factors for the development of MS (Ma et al. 2011; Sawcer et al. 2011).”
Backgroundthe Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 1×
“Microglia, the tissue macrophages of the brain, also express Axl and Mer (Gautier et al. 2012), and there is evidence that TAM signaling through these receptors controls the phagocytosis of ACs and the inhibition of inflammation in the CNS just as it does in macrophages and DCs in the periphery (Grommes et al.”
BackgroundSOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580 · cited 2×
“In so doing, Axl switches the IFNAR signaling modality from proinflammatory to immunosuppressive, by driving the activation of the genes encoding the suppressor of cytokine signaling (SOCS) 1 and 3 (Rothlin et al. 2007; Yoshimura et al. 2007).”
BackgroundRequirement for neuregulin receptor erbB2 in neural and cardiac development
Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,290 · cited 1×
“RTKs play essential roles in embryonic development, even single loss-of-function mutations in RTK genes often result in an embryonic-lethal phenotype (Gassmann et al. 1995; Lee et al. 1995; Soriano 1997; Arman et al. 1998).”
BackgroundActivation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhang, Z., Lee, J. C., Lin, L., Olivas, V., Au, V., LaFramboise, T., Abdel-Rahman, M., Wang, X., Levine, A. D., Rho, J. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2330 · Cited by 1,224 · cited 1×
“Axl up-regulation and activation have also been found to be a clinically significant feature of resistance to EGF receptor inhibitor and PI3K inhibitor therapies for nonsmall-cell lung cancer (Zhang et al. 2012; Byers et al. 2013).”
BackgroundPhagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 6×
“The TAMs play similarly critical roles in AC clearance by phagocytes of the immune system—most prominently macrophages (Scott et al. 2001).”
BackgroundInfluentialAberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., & Lemke, G. (1995) · Nature · doi:10.1038/378390a0 · Cited by 1,148 · cited 1×
“RTKs play essential roles in embryonic development, even single loss-of-function mutations in RTK genes often result in an embryonic-lethal phenotype (Gassmann et al. 1995; Lee et al. 1995; Soriano 1997; Arman et al. 1998).”
BackgroundSelf-citation
Cited by
Items 401–500 of 600
Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities
Hacking, S. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110227 · Cited by 6
“This hypothesis is based on the premise that PROS1 also functions as an activating ligand for TAM RTKs, in addition to functioning as an anticoagulant [24].”
Baugh, L. M., Goods, B. A., Gnecco, J. S., Bae, Y., Retchin, M. R., Tzouanas, C. N., Loring, M., Isaacson, K., Shalek, A. K., Lauffenburger, D. A., et al. (2022) · medRxiv · doi:10.1101/2022.01.29.22269829 · Cited by 3
“An increase in TAM receptor expression 619 with inflammation as an anti-inflammatory response(Lemke, 2013) and increased TAM 620 expression would presumably help with phagocytosis in the endometrium, however, both 621 phagocytosis(Weng et al.”
BackgroundKang, X., Gu, Q., Cheng, X., Jia, J., & Yan, T. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04222-z · Cited by 7
“Its expression is strongly upregulated in response to toll-like receptor (TLR) activation, driving the intracellular expression of suppressor of cytokine signaling (SOCS) proteins 1 and 3, which function to terminate inflammatory responses to pathogens [10, 12].”
Guan, G., Yu, C., Miao, L., Xiong, T., Sun, Y., Jin, X., Zhao, P., Lu, Y., Wang, L., Chen, P., et al. (2026) · Research · doi:10.34133/research.1122 · Cited by 6
“MerTK, a highly expressed phagocytic receptor on macrophages, undergoes proteolytic cleavage under inflammatory conditions to generate s-Mer, which inhibits efferocytosis [ 47 , 48 ].”
Microglia heterogeneity and therapeutic strategies in Parkinson’s disease
Tian, J., Liu, X., Wang, Z., Shi, X., Dai, C., & Yang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739341 · Cited by 6
Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?
Apostolo, D., D’Onghia, D., Nerviani, A., Ghirardi, G. M., Sola, D., Perazzi, M., Tonello, S., Colangelo, D., Sainaghi, P. P., & Bellan, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070444 · Cited by 5
“TAM is the acronym of Tyro3, Axl, and MerTK, a group of tyrosine kinase receptors [6].”
BackgroundAl‐Khrasani, M., Essmat, N., Boldizsár, I., Varga, B. T., Chalabiani, Y., Abbood, S. K., Ernyey, A. J., Király, K. P., Máté, A., Riba, P., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118346 · Cited by 8
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
Silina, L., Dufour, F., Rapinat, A., Réyès, C., Gentien, D., Maksut, F., Radvanyi, F., Verrelle, P., Bernard‐Pierrot, I., & Mégnin-Chanet, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158671 · Cited by 5
“In recent years several studies have established their involvement in the resolution of inflammation, autoimmunity and tumor immunology [13,14].”
BackgroundZhen, Y., Ren, Y., Medvedovic, M., Adams, D. E., Wang, D., & Shao, W.-H. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02965-w · Cited by 5
“Growth arrest-specific protein 6 (Gas6) is the ligand that binds to Axl with high affinity [7].”
BackgroundApostolo, D., Ferreira, L. L., Tizio, A. D., Ruaro, B., Patrucco, F., & Bellan, M. (2023) · Microorganisms · doi:10.3390/microorganisms11082038 · Cited by 5
“The activation and the consequ nt utophosphorylation of TAM receptors are followed by the downstream activation of several signaling cascades, such as the phospho nositide 3 kinase (PI3K)/AKT, mitogen-activated protein kinase (MAPK) or STAT1 activ ion by the hybrid TAM-IFNAR [12,13].”
BackgroundCancer Immunotherapy—An Emerging Field That Bridges Oncology and Immunology Research
Adams, J. L., Duffy, K. J., Moore, M. L., & Yang, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12400-x · Cited by 9
Zhang, X., Hong, H., Wang, X., Xie, Q., Miao, L., & Zhang, L. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.06.016 · Cited by 5
Viral apoptotic mimicry and the role of phosphatidylserine receptors
Brindley, M. A., & Pisciotta, M. A. (2025) · mSphere · doi:10.1128/msphere.00089-25 · Cited by 5
“Since many viruses induce an interferon response, activation of TAM receptors will suppress the IFN signaling and may enable enhanced replication (89).”
Gao, M., Zhou, J., Shi, N., Yan, X., & Liang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1742677 · Cited by 6
“Understanding the temporal regulation of PS exposure and TAM receptor expression is, therefore, critical for therapeutic intervention (76, 77).”
The Crossroads of Neuroinflammation and Biomarkers in Multiple Sclerosis: A Systematic Review
Gavrilă, M.-G., Albu, C. V., Albu, B. C., Burada, E., Sandu, R. E., & Surugiu, R. (2026) · Cells · doi:10.3390/cells15070610 · Cited by 4
“Emerging signals, such as stool GFAP [92–94] and extracellular vesicle-associated proteins [95–97], raise the possibility that systemic or gut–CNS axis mechanisms may contribute to sustained neuroinflammation.”
Apoptotic bodies in bone homeostasis and skeletal disease: biology and therapeutic implications
Xi, Y., Qu, Y., Zhang, Z. H., Xu, J., Luo, F., & Dou, C. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02386-z · Cited by 4
Li, C., Liu, W.-T., Fu, A.-N., Yang, H., & Yi, G. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.104957 · Cited by 5
Sawiris, M. M., Khalil, O. M., Halim, P. A., & Hassan, M. S. A. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70061 · Cited by 7
Itakura, K., Fujino, N., Kamide, Y., Saito, I., Yamada, M., Okutomo, K., Tsukita, Y., Saito, T., Ichikawa, T., Numakura, T., et al. (2022) · Allergology International · doi:10.1016/j.alit.2022.02.010 · Cited by 4
Katırcı, E., Konuk, E., Okan, A., Hidişoğlu, E., Cernomorcenco, A., Yargıçoğlu, P., Özen, Ş., & Demır, N. (2024) · Bioelectromagnetics · doi:10.1002/bem.22504 · Cited by 4
“The TAM ligands Gas 6 and Pros 1 contain an amino ‐ terminal Gla domain that is γ ‐ carboxylated in the presence of Vitamin K, four EGF ‐ like repeats, and a carboxy ‐ terminal sex hormone ‐ binding globulin ‐ like (SHBG ‐ like) module (Lemke, 2013).”
BackgroundTargeting TREM2 signaling shows limited impact on cerebrovascular calcification
Sridhar, S., Zhou, Y., Ibrahim, A., Bertazzo, S., Wyss, T., Swain, A., Maheshwari, U., Huang, S., Colonna, M., & Keller, A. (2024) · Life Science Alliance · doi:10.26508/lsa.202402796 · Cited by 4
“This cluster up-regulated both DAM and CAM marker genes (Fig 1F) Apoe , Lpl , Axl , Spp1 , Cst7 , Itgax , Ank , and Igf1 (Keren-Shaul et al, 2017) and down-regulated homeostatic genes P2ry12 , Csf1r , and Cx3cr1 , showing that the two states share a broad transcriptional signature (Fig 1E and F).”
BackgroundInfluentialZhang, S. N., An, N., Ouyang, X., Liu, Y. J., & Wang, X. K. (2020) · PubMed · doi:10.19723/j.issn.1671-167x.2021.01.003 · Cited by 4
Öz, Ö., Argon, A., Kebat, T. A., Akıncı, Ç. N., & Özdemir, Ö. (2022) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2022.2021-9-137 · Cited by 6
Tan, L., Huang, M., Qiu, X., Zhi, X., Liang, L., Sun, Y., Liao, Y., Song, C., Ren, T., & Ding, C. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199065 · Cited by 4
“Two soluble ligands, growth arrest specific 6 (GAS6) and protein S (PROS1), activate the TAM receptors (Lemke, 2013).”
BackgroundRepurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection
Zhang, D., Zhao, Y., You, X., He, S., & Li, E. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01487-22 · Cited by 9
“be a negative regulator of interferon pathways (15, 16).”
BackgroundTargeting AXL in mesothelioma: From functional characterization to clinical implication
Bhadresha, K. P., Mirza, S., Penny, C. B., & Mughal, M. J. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104043 · Cited by 4
Crockett, A. M., Fuhrmann, M., Garaschuk, O., & Davalos, D. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_5 · Cited by 4
Péterfi, L., Bjercke, T., Yusenko, M. V., Kovács, G., & Bányai, D. (2020) · Anticancer Research · doi:10.21873/anticanres.14335 · Cited by 5
COVID-19 Infection and Recurrent Stroke in Young Patients With Protein S Deficiency: A Case Report
Ali, L., Jamoussi, H., Kouki, N., Fray, S., Echebbi, S., Ali, N., & Fredj, M. (2021) · The Neurologist · doi:10.1097/nrl.0000000000000367 · Cited by 5
Wang, X., & Frye, S. V. (2014) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-800167-7.00019-5 · Cited by 5
Shreevatsa, B., Abhigna, N., Dharmashekar, C., Jain, A. S., Harendra, B., Siddalingegowda, S. V., Al‐Mazroua, H. A., Ahmad, S. F., Prasad, S. K., Srinivasa, C., et al. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1548269 · Cited by 3
“Adverse effects mainly include lymphopenia, increased risk of infections and other effects (Lemke, 2013).”
ACE2-independent entry factors for SARS-CoV-2 infection and immune activation
Sun, Y., Wong, L.-Y. R., & Chang, T. L.-Y. (2025) · mBio · doi:10.1128/mbio.01897-24 · Cited by 4
Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies
Adedayo, S. I., Gegele, T. A., Adeshina, K. A., Olukade, B. A., Abubakar, R. A., Abdulsalam, A., Oladejo, T. O., Ahmed, M. M., & Ibrahim, K. G. (2026) · Oxford Open Immunology · doi:10.1093/oxfimm/iqag001 · Cited by 4
Meng, C., Tao, S., Li, Y., Li, J., Huang, X., Xia, X., & Liu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1782933 · Cited by 6
“In a parallel and complementary recognition pathway, Gas6 and Protein S bind to PS via their Gla domains and subsequently activate TAM family receptors on phagocytes through their LG domains (51).”
Jin, C., Shen, D., Zhuang, Z., zhang, Q., Wu, Y., Hu, Z., Zhang, K., Li, L., Gu, Z., Hu, Y., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100447 · Cited by 4
Biomimetic lipid nanoparticles for macrophage reprogramming in cancer immunotherapy
고승효, Bae, G., Koh, E.-Y., Shin, S., Park, J. W., Shin, H. E., & Park, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115039 · Cited by 3
Zhao, Y., Chen, C., Chen, K., Sun, Y., He, N., Zhang, X., Xu, J., Shen, A., & Zhao, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-62668-x · Cited by 7
Sola, D., Bellan, M., Mai, S., Minisini, R., Perazzi, M., Brunani, A., Gentilli, S., Sainaghi, P. P., Scacchi, M., & Marzullo, P. (2024) · Medical Science Monitor · doi:10.12659/msm.944462 · Cited by 3
“It should also be acknowledged that the Gas6/TAM system is involved in the regulation of inflammatory response [17,18], tissue repair, fibrosis development [19,20], and vascular integrity [21,22], which are all crucial pathogenetic mechanisms of obesity complications.”
BackgroundBrunetti, M., Zeller, B., Tierens, A. M., Heim, S., Micci, F., & Panagopoulos, I. (2020) · Anticancer Research · doi:10.21873/anticanres.14632 · Cited by 3
The Synthesis and Initial Evaluation of MerTK Targeted PET Agents
Wang, L., Zhou, Y., Wu, X., Ma, X., Li, B., Ding, R., Stashko, M. A., Wu, Z., Wang, X., & Li, Z. (2022) · Molecules · doi:10.3390/molecules27051460 · Cited by 4
“In addition, due to the important physiological role of MerTK in the innate immune system, MerTK inhibitors may potentially reduce tumor growth by changing the immunosuppressive environment and stimulating antitumor immunity [10,11].”
BackgroundSu, C., Himes, J. E., & Kirsch, D. G. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.03.006 · Cited by 4
Apoptotic cells are not all created equal
Wong, A. O., & Ravichandran, K. S. (2025) · Science Immunology · doi:10.1126/sciimmunol.adv4682 · Cited by 3
Lemke, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_2 · Cited by 4
“The TAM receptors—Tyro3, Axl, and Mer—are an unusual family of receptor tyrosine kinases [ 1 ].”
BackgroundSelf-citationEndogenous DAMPs, Category III: Inducible DAMPs (Cat. III DAMPs)
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_14 · Cited by 3
Negi, V., Kuhn, R. J., & Fekete, D. M. (2023) · Viruses · doi:10.3390/v15010247 · Cited by 4
“After binding to their ligands, TAM RTKs dampen the type1 IFN response, the TLR-mediated response, and inflammation through the phosphorylation and activation of their tyrosine kinase intracellular domains [47].”
BackgroundReceptor Tyrosine Kinases and Their Ligands
Heldin, C., & Lennartsson, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30001-3 · Cited by 4
A novel hybrid protein promotes Aβ clearance and reduces inflammatory response through MerTKPreprint
Samentar, L., Salazar, A., Pan, P., Etebar, K., Choy, K., Uddin, D., Eliseeff, P., Bugayong, A. M., Garrido, J. A. M. G., Emini, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.03.467048 · Cited by 2
“MerTK signaling in macrophages promotes ERK activation and the resolution of inflammation by promoting the synthesis of inflammation resolution mediators (Lemke, 2013; Lemke and C. V. Rothlin, 2008; Rothlin et al., 2007).”
InfluentialEditorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins
Zizzo, G., & Cohen, P. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1251577 · Cited by 3
“It has been nearly 30 years since the discovery by multiple research groups of the receptor tyrosine kinase family now generally referred to as the TAM (Tyro3, Axl, and MerTK) receptors (1).”
BackgroundRunyan, C. E., Luo, L., Welch, L. C., Lu, Z., Chen, F., Schleck, M. J., Nafikova, R. A., Grant, R. A., Aillon, R. P., Senkow, K. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.09.631996 · Cited by 5
“MERTK is a tyrosine kinase expressed on the surface of macrophages and other cells 45 .”
Efferocytosis and infertility: Implications for diagnosis and therapy
Bavarsad, S. B., Shahryarhesami, S., Karami, N., Naseri, N., Tajbakhsh, A., & Hayat, S. M. G. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104413 · Cited by 4
Nutritional insights into pulmonary fibrosis: a comprehensive review on the impact of vitamins
Qu, Y., & Zhao, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1525408 · Cited by 5
“Growth arrest-specific 6 (GAS6) and protein S are also vitamin K-dependent proteins, which are important regulators of tissue repair after injury and may be involved in the pathogenesis of pulmonary fibrosis (194).”
AXL in cardiovascular diseases: Pathophysiological insights and clinical perspectives
Cheng, Q., Wang, C., & Liu, F. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156120 · Cited by 4
Zhao, Y., Nie, X., Li, T., Zhao, B., Wang, S., Zhang, L., Zhang, X., & Shan, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1653708 · Cited by 2
Yousaf, M., Arif, K., & Khan, D. (2025) · Discover Oncology · doi:10.1007/s12672-025-03632-7 · Cited by 2
“TAM family kinases are activated by Gas6 and Pros1, which in turn activate numerous signaling pathways, including PI3K/Akt and JAK/STAT [14], resulting in cell survival, progression of cancer, and adaptive resistance to various therapeutics.”
West Nile virus unmasked: from gene variability to future challenges
Prieto-Vega, S., Berzal‐Herranz, A., Garrido, J. J., Arias, A., Grande-Pérez, A., Fernández‐Escamilla, A. M., & Montoya, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1690827 · Cited by 4
“…3), TIM family proteins (TIM-1), and TAM receptor tyrosine kinases (Tyro3, Axl, Mer), often through bridging molecules like Gas6 or Protein S, or via phosphatidylserine interactions (Chu and Ng, 2004; Davis et al., 2006; Lemke, 2013; Moller-Tank et al., 2014; Niu et al., 2018; Anwar et al., 2022).”
Human oligodendrocyte progenitor cells mediate synapse elimination through TAM receptor activation
Gkogka, A., Malwade, S., Koskuvi, M., Ohtonen, S., Molnar, E., Bose, R., Ceccatelli, S., Koıstınaho, J., Tiihonen, J., Schalling, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66521-1 · Cited by 4
“3a) 43 – 47 .”
RTK AXL and its Isoforms: Regulation and Implications in Cancer
Malikova, I., Syzdykova, A., Islam, N., Kriajevskaia, M., & Tulchinsky, E. M. (2026) · Current Medicinal Chemistry · doi:10.2174/0109298673382005250828124053 · Cited by 2
Macrophage-associated kinase signaling in atherosclerosis – a systematic review
Müller, J. S., & van der Vorst, E. P. C. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02829-9 · Cited by 2
Moran, S. J., & Starbird, C. A. (2026) · Biochemical Society Transactions · doi:10.1042/bst20250119 · Cited by 2
Wang, L., Liu, K., Yu, J., & Sun, E. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.06.06 · Cited by 2
“Dysregulation of TAM signaling is associated with chronic inflammation, autoimmune diseases and cancers (29).”
BackgroundMiranda-Brand, Y., Bedoya, A. M., Betancur-Galvis, L. A., & Gallego-Gómez, J. C. (2022) · Microorganisms · doi:10.3390/microorganisms10122420 · Cited by 2
“Likewise, the AXL receptor, in addition to conferring susceptibility to the infection, can activate immunosuppressive molecules that regulate the antiviral response [12].”
BackgroundTeshigawara, T., Meguro, A., Takeuchi, M., Ishido, M., Soejima, Y., Hirahara, L., Kirino, Y., Ohno, S., & Mizuki, N. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2023.2173239 · Cited by 2
“21 Upon binding to TAM receptors, these ligands activate TAM receptor signaling, 10,22,23 which can induce negative regulation of the innate immune response to pathogens.”
BackgroundInfluence of serum Gas6 levels on prognosis in patients with hepatocellular carcinoma
Hayashi, M., Abe, K., Sugaya, T., Takahata, Y., Fujita, M., Takahashi, A., & Ohira, H. (2023) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyad132 · Cited by 2
Insight into Structure-Activity Relationship of New Compounds for Breast Cancer Treatment
Li, L., & Zhang, Q. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266253686230921054429 · Cited by 2
Bay, M., Seval, G. C., Coşkun, Ö., Gürman, G., & Özsoy, N. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4035 · Cited by 2
Distinct TYRO3 and PROS1 expression levels contribute to preeclampsia pathogenesis
Konuk, E., Katırcı, E., & Şimşek, M. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-024-02351-4 · Cited by 2
“…PROS1 binds to phosphatidylserine on apoptotic cells and to MERTK, facilitating their clearance and promoting the secretion of anti-inflammatory cytokines, which helps prevent chronic inflammation and maintain immune tolerance (Wu et al. 2021, Rovati et al. 2021, Lemke 2013, Zagórska et al. 2014).”
Agustini, D., Sabloak, R., Hasan, S., & Umar, T. P. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100041 · Cited by 3
Impaired Efferocytosis of Pericytes and Vascular Smooth Muscle Cells in Diabetic Retinopathy
Gardiner, T. A., Little, K., & Stitt, A. W. (2025) · Cells · doi:10.3390/cells14171349 · Cited by 2
“Some level of redundancy could also be expected with so many receptors targeted to PS; however, the TAM receptors and MerTK in particular appears indispensable [43,56] in the CNS.”
Toward inflammation-free therapeutics in Alzheimer’s disease
(2022) · Nature Medicine · doi:10.1038/s41591-022-01972-3 · Cited by 2
PEGylation of anti-MerTK Antibody Modulates Ocular Biodistribution
Vollmar, B. S., Fei, M., Liang, W., Bravo, D. D., Wang, J., Yu, L., Corr, N., Zhang, G., McNamara, E., Masih, S., et al. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00276 · Cited by 3
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Carrara, S. C., Bogen, J. P., Fiebig, D., Grzeschik, J., Hock, B. M., & Kolmar, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415673 · Cited by 2
“For RT-qPCR, iTaq Universal SYBR Green One-Step kit (Bio-Rad, Feldkirchen, Germany) was used, primers for Gapdh, Hprt1, MerTK, and Axl were ordered from IDT (Coralville, IA, USA), while the rest were ordered from Sigma Aldrich (Sequences in Table S1).”
BackgroundInfluentialLoss of Tyro3 causes anxiety-relevant behavioural changes in female mice
Thivisol, U., Binder, M. D., Hannan, A. J., & Pang, T. Y. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148319 · Cited by 2
Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy
Patil, D., & Bhatt, L. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00609-1 · Cited by 2
“Most receptor tyrosine kinases (RTKs) are triggered by ligand-facilitated dimerization, which results in the autophosphorylation of the TAM receptors’ tyrosine kinase domain [66].”
BackgroundImpaired Signaling of NF-κB and NRF2 in CX3CR1-Deficient Microglia: Implications in TauopathiesPreprint
Castro‐Sánchez, S., García‐Yagüe, Á. J., Kügler, S., & Lastres‐Becker, I. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/346304 · Cited by 2
“In the immune system, they act as pleiotropic inhibitors of the innate inflammatory response to pathogens (Lemke, 2013).”
BackgroundNg, M., Borst, R., Gacaferi, H., Davidson, S., Machado, C. C., Reekie, I. R., Attar, M., Windell, D., Kurowska‐Stolarska, M., MacDonald, L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.522218 · Cited by 2
“MerTK, a member of the Tyro-Axl-MERTK (TAM) family of receptor tyrosine kinases is a macrophage receptor that mediates efferocytosis(20, 21).”
BackgroundRole and Mechanisms of Tyro3 in Podocyte Biology and Glomerular Disease
Min, L., Chen, Y., Zhong, F., Gu, L., Lee, K., & He, C. (2024) · Kidney Diseases · doi:10.1159/000540452 · Cited by 1
“However, most studies on these pathways have focused on Axl and Mer in immune cells [19, 69].”
BackgroundPlasma MERTK is causally associated with infection mortality
Drozd, M., Hamilton, F., Cheng, C. W., Lillie, P. J., Brown, O. I., Chaddock, N., Savic, S., Naseem, K. M., Iles, M. M., Morgan, A. W., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106262 · Cited by 1
Aquib, A., Wang, Z., Gadiyar, V., Pulica, R., Varsanyi, C., Frederick, T., Tsou, W., Kimani, S. G., Sv, S., Lorenzo, M. S. D., et al. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.11.001 · Cited by 1
Hopkins, M. D., Zhang, D., Chen, Z., McIver, A. L., Huelse, J. M., Mahajan, J., Lyu, K., Yang, X., Stashko, M. A., Smith, B. M., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117561 · Cited by 1
Springborn, S., Judd, S., Morateck, P. A., VanderZee, D., Kidwell, A., Brzezinski, C. R., Cox, A., Sather, S., Neeves, K. B., DeRyckere, D., et al. (2025) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2025.100078 · Cited by 1
Roles of Glia in Synapse Nano-organization
Choi, Y., & Chung, W. (2026) · Advances in neurobiology · doi:10.1007/978-3-032-12594-1_11 · Cited by 2
Yang, Z., Cao, S., Zhang, J., Nie, X., Wang, Z., Yang, S., Wang, J., Sun, X., Kuang, X., Huang, H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02664-x · Cited by 2
“Because AXL is also present on host cells, such as M2 macrophages 6,27 and DCs, 28 we investigated whether the ef fi cacy of 6C5 involves targeting the host ’ s AXL.”
InfluentialVitamin K-dependent carboxylation in osteoblasts regulates bone resorption through GAS6 in male mice
Pata, M., Pham, D. N. T., Lacombe, J., Reddy, B. A., Kim, Y. W., Ahmed, A., Murshed, M., & Ferron, M. (2026) · Bone Research · doi:10.1038/s41413-026-00528-2 · Cited by 1
TYRO3 , AXL , MERTK and Their Ligands in Brain Metastases From Colorectal Cancers
Noblanc, A., Dkhissi, F., Guichet, P., Lebeau, L., Milin, S., Emambux, S., Roussille, P., Evrard, C., Karayan, L., Tougeron, D., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.71869 · Cited by 1
Immordino, B., Rocco, M. A., Comandatore, A., van der Zee, G., Vahabi, M., Morelli, L., & Giovannetti, E. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101408 · Cited by 1
Huang, X., Lu, C., Tan, Z., & Xu, J. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s597037 · Cited by 1
“44,45 Our findings suggest potential translational applications for CXCL12 in secondary lymphedema.”
Guo, J., Wen, Q., & Fan, S. (2026) · MedComm · doi:10.1002/mco2.70823 · Cited by 2
“These three receptors share two secreted ligands, protein S (PROS1) and growth-arrest-specific 6 (GAS6), both of which exhibit structural and functional homology [ 189, 190 ].”
Baker, B., Emerson, S., Tran, T., Mohapatra, N., Wang, D., Zaw, T., Doshi, A. A., Lopez, J.-M., Hassan, D., Kumar, P., et al. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2698782 · Cited by 1
“Practical approaches include receptor blockade, competitive decoys that sequester EV ligands, and surface editing to reduce high-avidity capture and internalization [8–11].”
Lv, Z., Zhang, Y., 邵天瑞, Wang, B., Lu, Q., Wang, J., Xu, H., Wu, T., Wang, K., Shi, H., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810549 · Cited by 1
“As a ligand of TAM receptor tyrosine kinases (Tyro3/Axl/Mer), PROS1 modulates inflammation and efferocytosis through activation of the Gas6– PROS1 pathway (Lemke, 2013; Stitt et al., 1995).”
Structural organization of TAM receptor ectodomains
Starbird, C. A., Zuo, Y., Walker, K., Stayrook, S. E., & Ferguson, K. M. (2026) · Biochemical Journal · doi:10.1042/bcj20260584 · Cited by 1
“Together with functional studies, these findings have established important roles for TAM receptors in processes including phagocytosis and negative regulation of immune responses [1,2,28].”
InfluentialDirk, B. S., Weir, G. M., Quinton, T., Hrytsenko, О., & Stanford, M. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-82108-4 · Cited by 1
Cardiovascular disorders in patients with Zika Virus: integrative review
Rezende, L. D. A., Freitas, P. D. S. S., Catabriga, D. D. S., Mocelin, H. J. S., Silva, K. E. D. J., Funabashi, L. M. S., & Fiorin, B. H. (2022) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v12i1.1210 · Cited by 1
Lighting the way to host-directed immunotherapeutics
van Tol, S., Hage, A., & Rajsbaum, R. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.06.009 · Cited by 1
“Because of AXL’s key role as a negative regulator of pro-inflammatory pathways and in the maintenance of tissue homeostasis through the clearance of apoptotic cells to prevent autoinflammatory diseases (Lemke, 2013), it will be important to evaluate the antiviral therapeutic potential for Gilteritinib in phagocytic ce…”
BackgroundInfluentialKöröskényi, K., Sós, L., Rostás, M., Papp, A. B., Kókai, E., Garabuczi, É., Deák, D., Beke, L., Méhes, G., & Szondy, Z. (2024) · Cells · doi:10.3390/cells13221902 · Cited by 1
In silico design, modelling and molecular mechanisms of Axl receptor tyrosine kinase inhibitors
Naresh, G. K. R. S., & Guruprasad, L. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2439578 · Cited by 1
“These receptors induce diverse signaling pathways to control cellular metabolic activities in different types of hormonal kinases such as protein kinase A, phospholipase C, serine/threonine kinases, and adenylate cyclase (Lemke, 2013).”
Limber, C., Wagner, G. P., & Prum, R. O. (2025) · Evolution & Development · doi:10.1111/ede.70016 · Cited by 3
“AXL is a receptor tyrosine kinase involved in signal transduction from the extracellular space to the cytoplasm (Dagamajalu et al. 2021; Lemke 2013 S3C).”
TAM family proteins and therapy resistance
McDaniel, N. K., Fischbach, S. R., Ondracek, O. J., Welke, N. B., Iida, M., & Wheeler, D. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817868-3.00008-1 · Cited by 1
Kwon, J., Park, Y., Kwon, H., Maeng, Y., Aldo, P. B., & Kim, S. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818508-7.00012-9 · Cited by 1
(EFSA), E. F. S. A. (2017) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2017.en-1220 · Cited by 1
Espíndola, M. S., Habiel, D. M., & Hogaboam, C. M. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201805-0972le · Cited by 1
Metadata
- Authors
- Lemke, G.
- Affiliations
- Salk Institute for Biological Studies (US)
- Corresponding author
- Lemke, G.
- ORCID
- Lemke, G.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2013-11-01
- Volume
- 5
- Issue
- 11
- Pages
- a009076-a009076
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3809585
- OpenAlex
- W2153326117
- Cited by
- 598
- References
- 184
- Citations by year
- 2026: 49 · 2025: 43 · 2024: 47 · 2023: 61 · 2022: 57 · 2021: 82 · 2020: 55 · 2019: 48 · 2018: 42 · 2017: 43 · 2016: 33 · 2015: 26 · 2014: 10 · 2013: 2
- Type
- posted content
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- TAM receptors, Tyro3, AXL, Mer, receptor tyrosine kinase, Gas6, protein S, efferocytosis, phagocytosis, innate immunity, inflammation, autoimmune disease, tumor progression, metastasis, drug resistance, tissue homeostasis
- MeSH terms
- c-Mer Tyrosine Kinase, Axl Receptor Tyrosine Kinase, Animals, Autoimmune Diseases, Cell Membrane, Gene Expression Regulation, Humans, Ligands, Neoplasms, Phagocytosis, Proto-Oncogene Proteins, Virus Diseases, Signal Transduction, Apoptosis, Receptor Protein-Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.